Target Price | HKD35.21 |
Price | HKD36.58 |
Deviation |
3.76%
register free of charge
|
Number of Estimates | 28 |
28 Analysts have issued a price target WuXi Biologics 2026 .
The average WuXi Biologics target price is HKD35.21.
This is
3.76%
register free of charge
HKD52.50
43.52%
register free of charge
HKD10.10
72.39%
register free of charge
|
|
A rating was issued by 32 analysts: 23 Analysts recommend WuXi Biologics to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the WuXi Biologics stock has an average upside potential 2026 of
3.76%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HKD | 20.40 | 23.85 |
9.63% | 16.79% | |
EBITDA Margin | 33.56% | 34.95% |
7.52% | 4.15% | |
Net Margin | 17.97% | 21.16% |
9.96% | 17.75% |
29 Analysts have issued a sales forecast WuXi Biologics 2025 . The average WuXi Biologics sales estimate is
This results in the following potential growth metrics:
29 WuXi Biologics Analysts have issued a net profit forecast 2025. The average WuXi Biologics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HKD | 0.86 | 1.24 |
1.18% | 44.19% | |
P/E | 28.82 | |
EV/Sales | 5.80 |
29 Analysts have issued a WuXi Biologics forecast for earnings per share. The average WuXi Biologics EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.